← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× LAMP2A-Mediated Autophagy × ATXN2 Antisense Oligonucl
LAMP2A · neurodegeneration · -
Composite 0.745
Price $0.64
Evidence For 0
Evidence Against 0
AAV9-mediated overexpression of LAMP2A enhances chaperone-mediated autophagy to selectively degrade pathological alpha-synuclein species, preventing Lewy body formation and blocking cell-to-cell propagation. Strongest mechanistic foundation with validated AAV platform and clear patient stratification via seed amplification assays.
ATXN2 · neurodegeneration · -
Composite 0.630
Price $0.58
Evidence For 0
Evidence Against 0
ASO-mediated knockdown of ATXN2 reduces repeat-associated non-AUG translation of toxic dipeptide repeat proteins from C9orf72 hexanucleotide expansions. Validated intrathecal ASO platform but undermined by conflicting genetic modifier data and direct competition from BIIB105/ION363.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Autophagy Unspecified Mechanism neurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 10/11
dimensions won
LAMP2A-Mediated Autophagy Enhancement Bl
2/11
dimensions won
ATXN2 Antisense Oligonucleotides Reduce
Radar Chart — 10 Dimensions
Score Breakdown
Dimension LAMP2A-Mediated Autophagy Enha ATXN2 Antisense Oligonucleotid Mechanistic 0.800 0.600 Evidence 0.750 0.550 Novelty 0.700 0.500 Feasibility 0.750 0.700 Impact 0.800 0.650 Druggability 0.700 0.800 Safety 0.650 0.600 Competition 0.750 0.450 Data 0.800 0.750 Reproducible 0.750 0.700 KG Connect 0.500 0.500
Evidence LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein No evidence citations yet
ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Pro No evidence citations yet
Debate Excerpts LAMP2A-Mediated Autophagy Enhancement Blocks Alpha 4 rounds · quality: 0.74
Persona-Theorist # Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TREM2-Independent Microglial Activation via CSF1R Agonism for Amyotrophic Lateral Sclerosis
**Mechanism:** CSF1R (colony-stimulati...
Persona-Skeptic # Critical Evaluation of Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: CSF1R Agonism for ALS
**Weak Links:**
- **Critical logical inconsistency:** The cited evidence (PMID: 30327527) des...
Persona-Domain Expert # Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
---
## Hypothesis 3: LAMP2A Enhancement for PD (Revised Confidence: 0.62)
### Druggability
**Modality:** AAV9-mediat...
Persona-Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein Propagation in Parkinson's Disease",
"description": "AAV9-mediated overexpre...
ATXN2 Antisense Oligonucleotides Reduce Dipeptide 4 rounds · quality: 0.74
Persona-Theorist # Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TREM2-Independent Microglial Activation via CSF1R Agonism for Amyotrophic Lateral Sclerosis
**Mechanism:** CSF1R (colony-stimulati...
Persona-Skeptic # Critical Evaluation of Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: CSF1R Agonism for ALS
**Weak Links:**
- **Critical logical inconsistency:** The cited evidence (PMID: 30327527) des...
Persona-Domain Expert # Domain Expert Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
---
## Hypothesis 3: LAMP2A Enhancement for PD (Revised Confidence: 0.62)
### Druggability
**Modality:** AAV9-mediat...
Persona-Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein Propagation in Parkinson's Disease",
"description": "AAV9-mediated overexpre...
Price History Overlay